Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics

References

• Ardizzone, S., Bianchi Porro, G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med 2002, 252, 475–496.
   PubMed Web of Science ®Google Scholar
• Asakura, H., Suzuki, K., Honma, T. Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol 2007, 13, 2145–2149.
   PubMedGoogle Scholar
• Kaser, A., Zeissig, S., Blumberg, R.S. Inflammatory bowel disease. Annu Rev Immunol 2010, 28, 573–621.
   PubMed Web of Science ®Google Scholar
• Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C.A., Madara, J.L., Hopkins, A.M., Nusrat, A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003, 171, 6164–6172.
   PubMed Web of Science ®Google Scholar
• Zhang, S.Z., Zhao, X.H., Zhang, D.C. Cellular and molecular immunopathogenesis of ulcerative colitis. Cell Mol Immunol 2006, 3, 35–40.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz, D., Stamler, J.S., Bachwich, D., Karmeli, F., Ackerman, Z., Podolsky, D.K. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Gut 1995, 36, 718–723.
   PubMed Web of Science ®Google Scholar
• Kolios, G., Valatas, V., Ward, S.G. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004, 113, 427–437.
   PubMed Web of Science ®Google Scholar
• Rafa, H., Amri, M., Saoula, H., Belkhelfa, M., Medjeber, O., Boutaleb, A., Aftis, S., Nakmouche, M., Touil-Boukoffa, C. Involvement of interferon-? in bowel disease pathogenesis by nitric oxide pathway: a study in Algerian patients. J Interferon Cytokine Res 2010, 30, 691–697.
   PubMed Web of Science ®Google Scholar
• Jurjus, A.R., Khoury, N.N., Reimund, J.M. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004, 50, 81–92.
   PubMedGoogle Scholar
• Wirtz, S., Neurath, M.F. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 2007, 59, 1073–1083.
   PubMed Web of Science ®Google Scholar
• Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., Nakaya, R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98, 694–702.
   PubMed Web of Science ®Google Scholar
• Cooper, H.S., Murthy, S.N., Shah, R.S., Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69, 238–249.
   PubMed Web of Science ®Google Scholar
• Murthy, S.N., Cooper, H.S., Shim, H., Shah, R.S., Ibrahim, S.A., Sedergran, D.J. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993, 38, 1722–1734.
   PubMed Web of Science ®Google Scholar
• Rioux, K.P., Fedorak, R.N. Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 2006, 40, 260–263.
   PubMed Web of Science ®Google Scholar
• Balfour Sartor, R. Microbial influences in inflammatory bowel diseases. Gastroenterol 2008, 134, 577–594.
   PubMed Web of Science ®Google Scholar
• Damaskos, D., Kolios, G. Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’. Br J Clin Pharmacol 2008, 65, 453–467.
   PubMed Web of Science ®Google Scholar
• Bengmark, S. Pre-, pro- and synbiotics. Curr Opin Clin Nutr Metab Care 2001, 4, 571–579.
   PubMed Web of Science ®Google Scholar
• Stall, A.M., Fariñas, M.C., Tarlinton, D.M., Lalor, P.A., Herzenberg, L.A., Strober, S., Herzenberg, L.A. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci USA 1988, 85, 7312–7316.
   PubMed Web of Science ®Google Scholar
• Elson, C.O., Sartor, R.B., Tennyson, G.S., Riddell, R.H. Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109, 1344–1367.
   PubMed Web of Science ®Google Scholar
• Arai, Y., Takanashi, H., Kitagawa, H., Okayasu, I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 1998, 10, 890–896.
   Google Scholar
• Southey, A., Tanaka, S., Murakami, T., Miyoshi, H., Ishizuka, T., Sugiura, M., Kawashima, K., Sugita, T. Pathophysiological role of nitric oxide in rat experimental colitis. Int J Immunopharmacol 1997, 19, 669–676.
   PubMed Web of Science ®Google Scholar
• Dijkstra, G., Moshage, H., van Dullemen, H.M., de Jager-Krikken, A., Tiebosch, A.T., Kleibeuker, J.H., Jansen, P.L., van Goor, H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998, 186, 416–421.
   PubMed Web of Science ®Google Scholar
• Morris, S.M., Jr, Billiar, T.R. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994, 266, E829–E839.
   PubMed Web of Science ®Google Scholar
• Drapier, J.C. [Nitric oxide and macrophages]. Pathol Biol 1997, 45, 110–114.
   PubMedGoogle Scholar
• Touil-Boukoffa, C., Bauvois, B., Sancéau, J., Hamrioui, B., Wietzerbin, J. Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie 1998, 80, 739–744.
   PubMed Web of Science ®Google Scholar
• Dieleman, L.A., Ridwan, B.U., Tennyson, G.S., Beagley, K.W., Bucy, R.P., Elson, C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994, 107, 1643–1652.
   PubMed Web of Science ®Google Scholar
• Singer, I.I., Kawka, D.W., Scott, S., Weidner, J.R., Mumford, R.A., Riehl, T.E., Stenson, W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996, 111, 871–885.
   PubMed Web of Science ®Google Scholar
• Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., Rao, A.S., Madara, J.L. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289, 1560–1563.
   PubMed Web of Science ®Google Scholar
• Petrof, E.O., Kojima, K., Ropeleski, M.J., Musch, M.W., Tao, Y., De Simone, C., Chang, E.B. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004, 127, 1474–1487.
   PubMed Web of Science ®Google Scholar
• McCarthy, J., O’Mahony, L., O’Callaghan, L., Sheil, B., Vaughan, E.E., Fitzsimons, N., Fitzgibbon, J., O’Sullivan, G.C., Kiely, B., Collins, J.K., Shanahan, F. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003, 52, 975–980.
   PubMed Web of Science ®Google Scholar
• Peña, J.A., Rogers, A.B., Ge, Z., Ng, V., Li, S.Y., Fox, J.G., Versalovic, J. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 2005, 73, 912–920.
   PubMed Web of Science ®Google Scholar
• Rigby, R.J., Knight, S.C., Kamm, M.A., Stagg, A.J. Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol 2005, 139, 245–256.
   PubMed Web of Science ®Google Scholar
• Ulisse, S., Gionchetti, P., D’Alò, S., Russo, F.P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M.G., Campieri, M., De Simone, C. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol 2001, 96, 2691–2699.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., Raz, E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126, 520–528.
   PubMed Web of Science ®Google Scholar
• Roberfroid, M.B., Van Loo, J.A., Gibson, G.R. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998, 128, 11–19.
   PubMed Web of Science ®Google Scholar
• Wollowski, I., Rechkemmer, G., Pool-Zobel, B.L. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001, 73, 451S–455S.
   PubMed Web of Science ®Google Scholar
• Satchithanandam, S., Vargofcak-Apker, M., Calvert, R.J., Leeds, A.R., Cassidy, M.M. Alteration of gastrointestinal mucin by fiber feeding in rats. J Nutr 1990, 120, 1179–1184.
   PubMed Web of Science ®Google Scholar
• Frankel, W., Zhang, W., Singh, A., Bain, A., Satchithanandam, S., Klurfeld, D., Rombeau, J. Fiber: effect on bacterial translocation and intestinal mucin content. World J Surg 1995, 19, 144–8; discussion 148.
   PubMedGoogle Scholar
• Videla, S., Vilaseca, J., Garcia-Lafuente, A., Antolin, M., Crespo, E., Guarner, F., Malagelada, JR. Dietary inulin prevents distal colitis induced by dextran sulfate sodium (DSS). Gastroenterol 1998, 114, A1110.
   Web of Science ®Google Scholar
• Kolida, S., Tuohy, K., Gibson, G.R. Prebiotic effects of inulin and oligofructose. Br J Nutr 2002, 87 Suppl 2, S193–S197.
   PubMedGoogle Scholar